Lupin (LUPIN) — Board Meeting

Lupin Limited's board approved the reappointment of Vinita Gupta as CEO for five years starting May 28, 2025, and Ramesh Swaminathan as Executive Director and Global CFO for five years starting March 26, 2025. The board also approved transferring its OTC Consumer Healthcare Business to a new subsidiary named LupinLife Consumer Healthcare Limited, with incorporation pending MCA approval and a slump sale expected by June 30, 2025. Additionally, the board formulated the Lupin Employees Stock Option Scheme 2025, authorizing up to 10 million stock options for eligible employees, subject to shareholder approval.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How does this board meeting affect Lupin Limited's outlook?" "What did Lupin Limited announce on 12 February 2025?" "Is this positive or negative for LUPIN?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 12 February 2025

APOLLOHOSP Apollo Hospitals Enterprise Limited Financial Results HAL Hindustan Aeronautics Limited Financial Results SIEMENS Siemens Limited Financial Results SIEMENS Siemens Limited Financial Results SBICARD SBI Cards and Payment Services Limited Corporate Action HAL Hindustan Aeronautics Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.